Myelodysplastic Syndrome Clinical Trials

52 studies are recruiting for myelodysplastic syndrome in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Houston, Texas 19 Duarte, California 13 Seattle, Washington 10 Boston, Massachusetts 9 Atlanta, Georgia 6 New York, New York 6 St Louis, Missouri 6 Chicago, Illinois 5 Cleveland, Ohio 5 Jacksonville, Florida 5 New Haven, Connecticut 5 Pittsburgh, Pennsylvania 5 Salt Lake City, Utah 5 Tampa, Florida 5 Aurora, Colorado 4 Baltimore, Maryland 4 Bethesda, Maryland 4 Columbus, Ohio 4 Iowa City, Iowa 4 Louisville, Kentucky 4 Madison, Wisconsin 4 Miami, Florida 4 New Brunswick, New Jersey 4 Portland, Oregon 4 Richmond, Virginia 4 The Bronx, New York 4 Winston-Salem, North Carolina 4 Albuquerque, New Mexico 3 Ann Arbor, Michigan 3 Birmingham, Alabama 3 Boise, Idaho 3 Buffalo, New York 3 Charleston, South Carolina 3 Charlottesville, Virginia 3 Danville, Pennsylvania 3 Des Moines, Iowa 3 Durham, North Carolina 3 Fairway, Kansas 3 Gainesville, Florida 3 Greenville, North Carolina 3 Greenville, South Carolina 3 Indianapolis, Indiana 3 Kansas City, Missouri 3 Knoxville, Tennessee 3 Lebanon, New Hampshire 3 Los Angeles, California 3 Maywood, Illinois 3 Minneapolis, Minnesota 3 Oklahoma City, Oklahoma 3 Orange, California 3 Orland Park, Illinois 3 Peoria, Illinois 3 Philadelphia, Pennsylvania 3 Rochester, Minnesota 3 Rochester, New York 3 Springfield, Illinois 3 Stony Brook, New York 3

Studies, page 3

  1. A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

    This is an open-label, dose escalation study to evaluate the safety, toxicity, and pharmacokinetics (PK) as well as preliminary efficacy of BTX-A51 capsules in participants with relapsed or refractory acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS). The study will be done i…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    City of Hope National Medical Center, Duarte, California
    Locations
    3 in total
    Run by
    Edgewood Oncology Inc.

    See if you can join NCT04243785 on ClinicalTrials.gov

  2. Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02

    An open-label, phase I, multi-center study to determine in relapsed/refractory (r/r) acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) patients the recommended dose of CYAD-02 after a non-myeloablative preconditioning chemotherapy followed by a potential CYAD-02 consolidation cycle for…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of Kansas Cancer Center, Fairway, Kansas
    Locations
    5 in total
    Run by
    Celyad Oncology SA

    See if you can join NCT04167696 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.